Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance.

Author: ColeJ, GreenM H, MoustacchiE, RigaudO, Sala-TrepatM, VilcoqJ R

Paper Details 
Original Abstract of the Article :
The mutant frequencies (MF) at the HPRT locus of peripheral blood lymphocytes collected from breast cancer patients before and after treatment according to a defined protocol of the Institut Curie were compared to those from healthy donors. The treatment involved either a local radiotherapy (RT1) fo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/mutage/5.6.593

データ提供:米国国立医学図書館(NLM)

Genotoxic Effects of Cancer Treatment: A Study in Cellular Damage

This study, published in [Journal Name], examines the genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in breast cancer patients. The researchers meticulously evaluate the mutant frequencies (MF) at the HPRT locus of peripheral blood lymphocytes before and after treatment, providing insights into the cellular damage caused by these therapies.

The Impact of Radiation on Lymphocyte Mutation

The study reveals that radiotherapy significantly increases the MF in circulating lymphocytes. This finding highlights the potential of radiation to induce genetic damage in these cells, underscoring the importance of minimizing radiation exposure and developing strategies to mitigate its genotoxic effects.

Protecting Cells from Treatment-Induced Damage

This research emphasizes the need for developing approaches to protect cells from the genotoxic effects of cancer therapies. By understanding the mechanisms of cellular damage, we can develop novel strategies to minimize side effects and improve patient outcomes.

Dr. Camel's Conclusion

This study reminds us that the battle against cancer often involves navigating a delicate balance between eradicating the disease and minimizing collateral damage. Just as a desert traveler seeks to minimize the risks of dehydration and exhaustion, we must strive to protect healthy cells while effectively targeting cancerous cells.

Date :
  1. Date Completed 1991-02-07
  2. Date Revised 2019-05-10
Further Info :

Pubmed ID

2263217

DOI: Digital Object Identifier

10.1093/mutage/5.6.593

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.